title: The role of ¹⁸F-FDG PET imaging in upper gastrointestinal malignancies.
abstract: Cancers of the upper gastrointestinal tract form a prevalent and highly morbid group of malignancies. Specifically, median survival for patients with esophagus, gastric, and pancreatic cancers is less than 1 year, and although there has been progress in therapeutic strategies, the vast majority of newly diagnosed patients with these cancers will die of their disease. (18)F-FDG PET ((18)f-fluorodeoxyglucose positron emission tomography) is a useful but underutilized resource for identifying metastatic disease in the upper gastrointestinal tract. While prevalent in the United States, worldwide, (18)F-FDG PET is underutilized especially in countries with a growing emergence of gastroesophageal cancers, despite evidence of clear benefit in cancer staging, and in some cases response assessment and surveillance.
authors: Weill Cornell Medical College of Cornell University, New York-Presbyterian Hospital, 1305 York Avenue, 12th Floor, New York, NY, 10021, USA.
authors: Tong
authors: T
authors: Dai
authors: Elizabeta
authors: E
authors: Popa
authors: Manish A
authors: MA
authors: Shah
mesh_terms: D019788:Fluorodeoxyglucose F18; D005770:Gastrointestinal Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging; D049268:Positron-Emission Tomography; D041742:Upper Gastrointestinal Tract / Q000000981:diagnostic imaging* / Q000473:pathology*
chemical_list: D019788:Fluorodeoxyglucose F18